In this video, we will discuss that As the global burden of obesity continues to rise, the medical community is embracing less invasive solutions that offer effective, sustainable weight loss with minimal risk. In this enlightening video, Dr. G.S. Prabudoss, a respected voice in bariatric and minimal access surgery, delves into the evolving role of Endoscopic Sleeve Gastroplasty (ESG)—a revolutionary, non-surgical approach to managing obesity. Titled "Endoscopic Sleeve Gastroplasty: Current Status and Future Prospects," this presentation highlights ESG’s emergence as a key player in the landscape of endoscopic bariatric therapies.
Understanding ESG: A Minimally Invasive Milestone
Endoscopic Sleeve Gastroplasty is a scarless, incision-free weight loss procedure performed via flexible endoscopy. It involves the placement of full-thickness sutures within the stomach to reduce its volume by approximately 70%, mimicking the anatomical effects of a surgical sleeve gastrectomy—but without resecting tissue. ESG is increasingly favored for its ability to deliver meaningful weight loss while preserving natural gastrointestinal continuity.
Key Insights Shared by Dr. Prabudoss in the Video
Current Clinical Status of ESG
ESG is now supported by multiple international studies demonstrating its safety, reproducibility, and sustained weight loss outcomes. Patients typically achieve 15–20% total body weight loss within 12 months post-procedure.
Patient Selection and Indications
Dr. Prabudoss emphasizes the importance of proper patient selection, targeting individuals with BMI between 30–40 kg/m², or those unwilling or unfit for traditional bariatric surgery.
Procedure Technique and Technological Advancements
With modern endoscopic suturing platforms like OverStitch, ESG has become more efficient and durable. Dr. Prabudoss walks viewers through the endoluminal technique, stressing the importance of symmetry and tension for long-term durability.
Advantages Over Traditional Bariatric Surgery
ESG offers no external scars, faster recovery, reduced complications, and can often be performed as a day-care procedure. It preserves hormonal balance by retaining the fundus and antrum, potentially minimizing risks like dumping syndrome.
Limitations and Challenges
Dr. Prabudoss addresses areas that still require attention—such as long-term data, access to trained endoscopists, and standardization of technique across centers.
Future Prospects
As the demand for less invasive bariatric solutions grows, ESG is poised to become a first-line intervention for obesity management, especially in younger, health-conscious populations and those in early disease stages. The future may see combination therapies, AI-assisted suturing, and insurance-backed coverage further accelerating ESG’s adoption.
Conclusion
Through his insightful commentary, Dr. Prabudoss paints a promising picture for Endoscopic Sleeve Gastroplasty—not just as an alternative to surgery, but as a paradigm shift in the treatment of obesity. ESG represents the future of metabolic intervention: effective, safe, reversible, and accessible.
Watch the full video to gain expert insights into how ESG is changing the face of obesity treatment and why it’s set to become a cornerstone of modern endoscopic bariatric practice. Don’t forget to like, comment, and subscribe for more updates on cutting-edge innovations in minimal access surgery.